From the street to the brain: Neurobiology of the recreational drug γ-hydroxybutyric acid

Trends in Pharmacological Sciences

Volumn 25, Issue 1, 2004, Pages 29-34

  Wong, C Guin Ting ^a   Gibson, K Michael ^b   Snead III, O Carter ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 3 AMINOPROPYLBUTYLPHOSPHINIC ACID; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 4 HYDROXYBUTYRIC ACID; ANESTHETIC AGENT; ANTIDOTE; BACLOFEN; DOPAMINE; NCS 382; NEUROTRANSMITTER; PROGESTERONE; RECEPTOR; RECEPTOR BLOCKING AGENT; SHORT CHAIN FATTY ACID; UNCLASSIFIED DRUG;

ADDICTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANALGESIA; ANTEROGRADE AMNESIA; BEHAVIOR; BRAIN; CARDIOPULMONARY INSUFFICIENCY; COMA; CONCENTRATION (PARAMETERS); DEATH; DERIVATIZATION; DOSE RESPONSE; DROWSINESS; DRUG ABUSE; DRUG ACTIVITY; DRUG EFFECT; DRUG OVERDOSE; DRUG TOLERANCE; DRUG USE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; ELECTROPHYSIOLOGY; EUPHORIA; HUMAN; IC 50; INTOXICATION; LETHAL DOSE; MAMMAL; MEMORY DISORDER; NARCOLEPSY; NEUROBIOLOGY; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; REVIEW; REWARD; SEDATION; SEIZURE; SHORT TERM MEMORY; SLEEP; STUPOR; SURVIVAL; TRANQUILIZING ACTIVITY; UPREGULATION;

EID: 0346024000     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2003.11.001     Document Type: Review

References (64)

1. Vickers M.D. Gamma hydroxybutyric acid. Int. Anesthesiol. Clin. 7:1969;75-79.
2. Wong C.G.T., et al. GABA, γ-hydroxybutyric acid, and neurological disease. Ann. Neurol. 54:(Suppl. 6):2003;S3-12.
3. Freese T.E., et al. The effects and consequences of selected club drugs. J. Subst. Abuse Treat. 23:2002;151-156.
4. Raess B.U., Tunnicliff G. Abuse potential and toxicology of γ-hydroxybutyrate. Tunnicliff G., Cash C.D. Gamma-Hydroxybutyate. 2002;188-196 Taylor & Francis.
5. Smith K.M., et al. Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate. Am. J. Health Syst. Pharm. 59:2002;1067-1076.
6. Shannon M., Quang L.S. Gamma-hydroxybutyrolactone, 1, 4-butanediol: a case report and review of the literature. Pediatr. Emerg. Care. 16:2000;435-440.
7. Maitre M. The γ-hydroxybutyrate signaling system in brain: organization and functional implications. Prog. Neurobiol. 51:1997;337-361.
8. Hogema B.M., et al. Pharmacological rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase. Nat. Genet. 29:2001;212-216.
9. Hedou G., et al. Immunohistochemical studies of the localization of neurons containing the enzyme that synthesizes dopamine, GABA or γ-hydroxybutyrate in the rat substantia nigra and striatum. J. Comp. Neurol. 426:2000;549-560.
10. Muller C., et al. Evidence for a γ-hydroxybutyrate (GHB) uptake by rat brain synaptic vesicles. J. Neurochem. 80:2002;899-904.
11. Andriamampandry C., et al. Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator gamma-hydroxybutyrate (GHB). FASEB J. 17:2003;1691-1693.
12. Bernasconi R., et al. Gamma-hydroxybutyric acid: an endogenous neuromodulator with abuse potential? Trends Pharmacol. Sci. 20:1999;135-141.
13. Miotto K., et al. Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal. Am. J. Addict. 10:2001;232-241.
14. Craig K., et al. Severe gamma-hydroxybutyrate withdrawal: a case report and literature review. J. Emerg. Med. 18:2000;65-70.
15. Bania T.C., et al. Gamma-hydroxybutyric acid tolerance and withdrawal in a rat model. Acad. Emerg. Med. 10:2003;697-704.
16. Van Sassenbroeck D.K., et al. Tolerance to the hypnotic and electroencephalographic effect of gamma-hydroxybutyrate in the rat: pharmacokinetic and pharmacodynamic aspects. J. Pharm. Pharmacol. 55:2003;609-615.
17. Martellotta M.C., et al. Rewarding properties of gamma-hydroxybutyric acid: an evaluation through place preference paradigm. Psychopharmacology (Berl.). 132:1997;1-5.
18. Colombo G., et al. Behavioral pharmacology of γ-hydroxybutyrate. Tunnicliff G., Cash C.D. Gamma Hydroxybutyrate. 2002;150-168 Taylor & Francis.
19. Fattore L., et al. Baclofen antagonizes intravenous self-administration of gamma-hydroxybutyric acid in mice. Neuroreport. 12:2001;2243-2246.
20. Zvosec D.L., et al. Unsupported 'efficacy' claims of gamma hydroxybutyrate (GHB). Acad. Emerg. Med. 10:2003;95-96.
21. Addolorato G., et al. An open multicenter study evaluating 4-hydroxybutyric acid sodium salt in the medium term treatment of 179 alcohol dependant subjects. Alcohol Alcohol. 31:1996;341-345.
22. Beghe F., Carpanini M.T. Safety and tolerability of gamma-hydroxybutyric acid in the treatment of alcohol-dependant patients. Alcohol. 20:2000;223-225.
23. Addolorato G., et al. A Case of gamma-hydroxybutyric acid withdrawal during alcohol addiction treatment: utility of diazepam administration. Clin. Neuropharmacol. 22:1999;60-62.
24. Caputo F., et al. Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study. Drug Alcohol Depend. 70:2003;85-91.
25. Van Sassenbroeck D.K., et al. Characterization of the pharmacokinetic and pharmacodynamic interaction between gamma-hydroxybutyrate and ethanol in the rat. Toxicol. Sci. 73:2003;270-278.
26. Bowery N.G., et al. International Union of Pharmacology. XXXIII. mammalian γ-aminobutyric acid b receptors: structure and function. Pharmacol. Rev. 54:2002;247-264.
27. Mathivet P., et al. Binding characteristics of gamma-hydroxybutyric acid as a weak but selective GABAB receptor agonist. Eur. J. Pharmacol. 321:1997;67-75.
28. Lingenhoehl K., et al. Gamma-hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors. Neuropharmacology. 38:1999;1667-1673.
29. Hechler V., et al. Gamma-hydroxybutyrate conversion into GABA induces displacement of GABAB binding that is blocked by valproate and ethosuximide. J. Pharmacol. Exp. Ther. 281:1997;753-760.
30. Kaufmann E.E. Metabolism and distribution of γ-hydroxybutyrate in the brain. Tunnicliff G., Cash C.D. Gamma-Hydroxybutyrate. 2002;1-16 Taylor & Francis.
31. B) receptor in rat brain. Biochem. Pharmacol. 52:1996;1235-1243.
32. Kemmel V., et al. Neurochemical and electrophysiological evidence for the existence of a functional gamma-hydroxybutyrate system in NCB-20 neurons. Neuroscience. 86:1998;989-1000.
33. B binding sites: relation to the development of experimental absence seizures. Brain Res. 659:1994;147-156.
34. Snead O.C. III. Evidence for a G protein-coupled γ-hydroxybutyric acid receptor. J. Neurochem. 75:2000;1986-1996.
35. Castelli M.P., et al. Quantitative autoradiographic distribution of gamma-hydroxybutyric acid binding sites in human and monkey brain. Brain Res. Mol. Brain Res. 78:2000;91-99.
36. B receptors. Soc. Neurosci. Abstr. 26:2000;1660.
37. B receptors. Neurosci. Lett. 216:1996;121-124.
38. B receptors. Naunyn Schmiedebergs Arch. Pharmacol. 357:1998;611-619.
39. Crunelli V., Leresche N. Action of γ-hydroxybutyrate on neuronal excitability and underlying membrane conductances. Tunnicliff G., Cash C.D. Gamma-Hydroxybutyrate. 2002;75-110 Taylor & Francis.
40. Eckstein M., et al. Gamma hydroxybutyrate (GHB): report of a mass intoxication and review of the literature. Prehosp. Emerg. Care. 3:1999;357-361.
41. Li J., et al. A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management. Ann. Emerg. Med. 31:1998;729-736.
42. Colombo G., et al. Behavioral pharmacology of γ-hydroxybutyrate. Tunnicliff G., Cash C.D. Gamma-Hydroxybutyrate. 2002;150-168 Taylor & Francis.
43. Carai M.A., et al. Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid. Eur. J. Pharmacol. 428:2001;315-321.
44. Snead O.C. γ-Hydroxybutyrate and absence seizure activity. Tunnicliff G., Cash C.D. Gamma-Hydroxybutyrate. 2002;120-131 Taylor & Francis.
45. Kemmel V., et al. γ-Hydroxybutyrate receptor function determined by stimulation of rubidium and calcium movements from NCB-20 neurons. Neuroscience. 116:2003;1021-1031.
46. Godbout R., et al. Effect of gamma-hydroxybutyrate and its antagonist NCS-382 on spontaneous cell firing in the prefrontal cortex of the rat. Brain Res. 673:1995;157-160.
47. Jensen K., Mody I. GHB depresses fast excitatory and inhibitory synaptic transmission via GABA(B) receptors in mouse neocortical neurons. Cereb. Cortex. 11:2001;424-429.
48. Madden T.E., Johnson S.W. Gamma-hydroxybutyrate is a GABAB receptor agonist that increases a potassium conductance in rat ventral tegmental dopamine neurons. J. Pharmacol. Exp. Ther. 287:1998;261-265.
49. B) receptor-mediated release of GABA and glutamate (GLU) in rat thalamic ventrobasal nucleus (VB): a possible mechanism for the generation of absence-like seizures induced by GHB. J. Pharmacol. Exp. Ther. 273:1995;1534-1543.
50. Gobaille S., et al. γ-Hydroxybutyrate modulates synthesis and extracellular concentration of γ-aminobutyric acid in discrete brain regions in vivo. J. Pharmacol. Exp. Ther. 290:1999;303-309.
51. B/γ-hydroxybutyric acid (GHB) receptor complex in rat. Neuropharmacology. 39:2000;427-439.
52. Tanganelli F., et al. Gamma-hydroxybutyrate modulation of glutamate levels in the hippocampus: an in vivo and in vitro study. J. Neurochem. 78:2001;929-939.
53. Schmidt-Mutter C., et al. Gamma-hydroxybutyrate and cocaine administration increases mRNA expression of dopamine D1 and D2 receptors in rat brain. Neuropsychopharmacology. 21:1999;662-669.
54. Howard S.G., Banerjee P.K. Regulation of central dopamine by γ-hydroxybutyrate. Tunnicliff G., Cash C.D. Gamma-Hydroxybutyrate. 2002;111-119 Taylor & Francis.
55. Nissbrandt H., Engberg G. The GABAB-receptor antagonist, CGP 35348, antagonizes gamma-hydroxybutyrate- and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice. J. Neural Transm. 103:1996;1255-1263.
56. Itzhak Y., Ali S.F. Repeated administration of gamma-hydroxybutyric acid (GHB) to mice: assessment of the sedative and rewarding effects of GHB. Ann. New York Acad. Sci. 965:2002;451-460.
57. Carai M.A., et al. Central effects of 1,4-butanediol are mediated by GABA(B) receptors via its conversion into gamma-hydroxybutyric acid. Eur. J. Pharmacol. 441:2002;157-163.
58. Bottiglieri T., et al. Effect of Gamma-hydroxybutyrate on locomotor activity and brain dopamine metabolism in the rat. J. Neurosci. Abstr. 27:2001;971.
59. Perroy J., et al. Phosphorylation-independent desensitization of GABA(B) receptor by GRK4. EMBO J. 22:2003;3816-3824.
60. Maitre M., et al. The role of γ-hydroxtbutyrate in brain function. Tunnicliff G., Cash C.D. Gamma-Hydroxybutyrate. 2002;236-248 Taylor & Francis.
61. Barbaccia M.L., et al. GABA(B) receptor-mediated increase of neurosteroids by gamma-hydroxybutyric acid. Neuropharmacology. 42:2002;782-791.
62. Hamilton N.M. Interaction of steroids with the GABA(A) receptor. Curr. Top. Med. Chem. 2:2002;887-902.
63. Sundstrom I., et al. Patients with premenstrual syndrome have a different sensitivity to neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology. 67:1998;126-138.
64. Gupta M., et al. Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (γ-hydroxybutyric aciduria). J. Pharmacol. Exp. Ther. 302:2002;180-187.